concept

Aβ CLEARANCE

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about Aβ CLEARANCE: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

30Connections

4Hypotheses

10Analyses

0Outgoing

30Incoming

0Experiments

12Debates

No summary available yet.

View on Wiki →

No AI portrait yet

💡 Concept Info

Name	Aβ CLEARANCE

Pathway Diagram

graph TD
    A__CLEARANCE[Aβ CLEARANCE]
    SQSTM1[SQSTM1] -->|involved_in| A__CLEARANCE
    MAP1LC3B[MAP1LC3B] -->|involved_in| A__CLEARANCE
    Astrocytic_Autophagy[Astrocytic Autophagy] -->|promotes| A__CLEARANCE
    ASTROCYTES[ASTROCYTES] -->|mediates| A__CLEARANCE
    astrocytic_autophagy[astrocytic autophagy] -->|modulates| A__CLEARANCE
    Autophagy[Autophagy] -->|mediates| A__CLEARANCE
    LPL[LPL] -->|modulates| A__CLEARANCE
    Autophagy_Induction[Autophagy Induction] -->|mediates| A__CLEARANCE
    ASTROCYTE[ASTROCYTE] -->|mediates| A__CLEARANCE

Outgoing (0)

Target	Relation	Type	Str
No outgoing edges

Incoming (30)

Source	Relation	Type	Str
SQSTM1	involved_in	gene	0.95
MAP1LC3B	involved_in	gene	0.94
Astrocytic Autophagy	promotes	process	0.94
ASTROCYTES	mediates	cell_type	0.93
TREM2 agonism	activates	drug	0.90
astrocytic autophagy	modulates	process	0.90
Autophagy	mediates	process	0.87
TREM2	enhances	gene	0.80
LPL	modulates	gene	0.80
SYK	associated_with	gene	0.80
Autophagy Induction	mediates	process	0.80
ASTROCYTE	mediates	cell_type	0.80
Lyso-ChR2	associated_with	protein	0.80
ASTROCYTES	mediates	cell_type	0.80
AUTOPHAGY	promotes	process	0.80
APOE	regulates	gene	0.70
pericyte-specific PDGFRβ signaling	regulates	process	0.70
autophagy	activates	process	0.70
LRP1	regulates	protein	0.70
PDGFRβ signaling	regulates	pathway	0.70
LRP1	regulates	protein	0.70
C1q	associated_with	protein	0.70
Trem2	regulates	protein	0.70
C1q	modulates	protein	0.70
Lipidated APOE	enhances	protein	0.70
LRP1	enhances	gene	0.70
LRP1	modulates	protein	0.70
Trem2 Agonism	enhances	phenotype	0.70
TFEB	enhances	gene	0.70
CCR2+ monocytes	inhibits	cell_type	0.70

Targeting Hypotheses (4)

Hypotheses where this entity is a therapeutic target

Hypothesis	Score	Disease	Analysis
Soluble LRP1 (sLRP1) Ectodomain Shedding as a Blood-Based In	0.680	-	What blood-brain barrier permeability ch
Reactive astrocyte glutamate-handling failure sustains dendr	0.490	neurodegeneration	Does tau dendritic missorting persist in
CYP2J2-Derived DHA Epoxides Modulate Microglial M2 Polarizat	0.380	lipidomics	Lipid metabolism dysregulation in Alzhei
Personalized Microbiome Restoration Based on Individual Aβ C	0.000	-	Gut-Brain Axis Therapeutics for Alzheime

Mentioning Analyses (10)

Scientific analyses that reference this entity

What blood-brain barrier permeability changes serve as early biomarkers for neur

neurodegeneration | 2026-04-26 | 8 hypotheses Top: 0.940

Why do p300/CBP inhibitors reduce both AD incidence and clinically diagnosed TBI

neurodegeneration | 2026-04-14 | 1 hypotheses Top: 0.604

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

neurodegeneration | 2026-04-12 | 0 hypotheses

Does SYK activation provide neuroprotection or exacerbate neuroinflammation in e

neurodegeneration | 2026-04-11 | 0 hypotheses

How do perivascular cells specifically recognize and respond to amyloid-β to upr

neurodegeneration | 2026-04-06 | 7 hypotheses Top: 0.618

Experiments (0)

Experimental studies targeting or related to this entity

Experiment	Type	Disease	Score	Feasibility	Model	Status	Est. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMID	Authors	Journal	Year	Citations
No papers found

Debates (12)

Multi-agent debates referencing this entity

What blood-brain barrier permeability changes serve as early biomarkers for neur

closed · Rounds: 4 · Score: 1.00 · 2026-04-26

What mechanisms govern antibody transport across the blood-brain barrier and how

closed · Rounds: 4 · Score: 0.82 · 2026-04-22

Lysosomal membrane permeabilization releasing cathepsins triggers NLRP3 inflamma

closed · Rounds: 4 · Score: 0.76 · 2026-04-22

The abstract indicates SPP1 upregulation occurs in perivascular macrophages and

closed · Rounds: 4 · Score: 0.67 · 2026-04-22

The debate revealed fundamental uncertainty about whether enhancing TYROBP-SYK s

closed · Rounds: 4 · Score: 0.30 · 2026-04-21

The debate revealed conflicting evidence about C1q's role - some studies show it

closed · Rounds: 4 · Score: 0.58 · 2026-04-16

The observation that salsalate and diflunisal decrease both AD and TBI incidence

closed · Rounds: 4 · Score: 0.95 · 2026-04-16

How do peripheral immune system alterations influence CNS pathology and neurodeg

closed · Rounds: 4 · Score: 0.76 · 2026-04-12

How do peripheral immune system alterations influence CNS pathology and neurodeg

closed · Rounds: 4 · Score: 0.78 · 2026-04-12

How do alterations in brain lipid metabolism—including gangliosides, phospholipi

closed · Rounds: 4 · Score: 0.84 · 2026-04-11

Related Research

Hypotheses and analyses mentioning Aβ CLEARANCE in their description or question text

No additional research found

Aβ CLEARANCE

Understanding Entity Pages

Pathway Diagram

Outgoing (0)

Incoming (30)

Targeting Hypotheses (4)

Mentioning Analyses (10)

What blood-brain barrier permeability changes serve as early biomarkers for neur

Why do p300/CBP inhibitors reduce both AD incidence and clinically diagnosed TBI

Is C1q elevation in AD pathogenic or compensatory for amyloid clearance?

Does SYK activation provide neuroprotection or exacerbate neuroinflammation in e

How do perivascular cells specifically recognize and respond to amyloid-β to upr

TREM2 Therapeutic Strategy Post-INVOKE-2

Systemic immune profiling and peripheral immune contributions to neurodegenerati

Lipid metabolism dysregulation and membrane integrity in Alzheimer disease

Lysosomal dysfunction and cathepsin leakage in Alzheimer disease progression

Blood-brain barrier antibody transport mechanisms

Experiments (0)

Related Papers (0)

Debates (12)

What blood-brain barrier permeability changes serve as early biomarkers for neur

What mechanisms govern antibody transport across the blood-brain barrier and how

Lysosomal membrane permeabilization releasing cathepsins triggers NLRP3 inflamma

The abstract indicates SPP1 upregulation occurs in perivascular macrophages and

The debate revealed fundamental uncertainty about whether enhancing TYROBP-SYK s

The debate revealed conflicting evidence about C1q's role - some studies show it

The observation that salsalate and diflunisal decrease both AD and TBI incidence

How do peripheral immune system alterations influence CNS pathology and neurodeg

How do peripheral immune system alterations influence CNS pathology and neurodeg

How do alterations in brain lipid metabolism—including gangliosides, phospholipi

Related Research